EYEG - EyeGate Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
2,686
1,653
408
669
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
5,329
8,056
10,330
8,423
Selling General and Administrative
4,339
4,441
4,636
5,594
Total Operating Expenses
9,668
12,497
14,967
14,016
Operating Income or Loss
-6,982
-10,845
-14,559
-13,347
Interest Expense
0
1
1
0
Total Other Income/Expenses Net
-
-
-
0
Income Before Tax
-6,837
-10,725
-14,560
-13,343
Income Tax Expense
-
86
-1,342
-
Income from Continuing Operations
-6,923
-10,811
-13,218
-13,343
Net Income
-6,923
-10,811
-13,218
-13,343
Net Income available to common shareholders
-6,923
-10,811
-13,218
-13,343
Reported EPS
Basic
-
-4.50
-13.95
-22.65
Diluted
-
-4.50
-13.95
-22.65
Weighted average shares outstanding
Basic
-
2,366
951
589
Diluted
-
2,366
951
589
EBITDA
-
-10,686
-14,539
-13,338